Work

Use of digital PCR to detect variability in circulating tumor DNA level among colorectal cancer patients with different metastatic sites

Year: 2024
Type: article
Abstract: Circulating tumor DNA (ctDNA), a tumor-specific DNA released into the bloodstream from tumors, is gaining recognition as a novel biomarker for assessing tumor activity within the body.However, reports suggest that the detection of ctDNA varies based on the type of cancer and the organ tissue affected by metastasis.We examined whether digital PCR (dPCR) could be used to detect ctDNA in patients with colorectal cancer with metastases, which are considered difficult to detect.We identified case-specific mutations from primary tumor tissues using next-generation sequencing and detected ctDNA in blood through dPCR.We detected ctDNA in 3 patients with liver metastases, 4 with lung metastases, 1 with lymph node metastasis, and 2 with peritoneal metastasis.The mutation allele frequency of non-liver metastases was lower than that of liver metastases (liver vs. non-liver metastases, 13 .1 [ 0 .35 -22.3] vs. 0.1 [0 -5.2], p = 0.11); however, ctDNA could be detected in all patients.This detection system has the potential for clinical application of ctDNA for colorectal cancer with distant metastasis. Key words: circulating tumor DNA, digital PCR, next generation sequence, metastatic colorectal cancer
Authors: 大塚, 観喜, Otsuka, Kanki
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7062659474
FWCI:
Cites: 28
Cited by:
Related to: 9